Alan H. Auerbach
Chief Executive Officer,
puma biotechnology
Canada
Biography
Alan H. Auerbach has served as our Chairman of the Board and as our Chief Executive Officer and President since our inception. Prior to founding Puma, Mr. Auerbach served as Founder, Chief Executive Officer, President and a Member of the Board of Directors of Cougar Biotechnology, Inc., from the company's inception in 2003 until its acquisition by Johnson & Johnson in July 2009. Alan H. Auerbach has served as our Chairman of the Board and as our Chief Executive Officer and President since our inception. Prior to founding Puma, Mr. Auerbach served as Founder, Chief Executive Officer, President and a Member of the Board of Directors of Cougar Biotechnology, Inc., from the company's inception in 2003 until its acquisition by Johnson & Johnson in July 2009.
Research Interest
From July 2009 until January 2010, Mr. Auerbach served as Co-Chairman of the Integration Steering Committee at Cougar (as part of Johnson & Johnson) that provided leadership and oversight for the development and global commercialization of Cougar's lead product candidate, abiraterone acetate. Abiraterone was approved for the treatment of metastatic prostate cancer in the U.S. in April 2011 and in the European Union in September 2011.
